Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity

NCT04837183 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-07-03

No results posted yet for this study

Summary

This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrhythmias respond to catheter ablation treatment.

Conditions

  • Ventricular Tachycardia

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    collaborator OTHER
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Yong-Mei Cha, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04837183 on ClinicalTrials.gov